Serina Therapeutics, Inc. SER
2.09
(0.05)
(2.34%)
as of 25 Sep
- Market cap
- $54.4M
- P/E
- 0.0×
Follow SER
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (306.22%) | (298.55%) | 858.45% | 217.81% |
+8 more TTM periods Free account |
|
| (136.00%) | (124.99%) | (280.54%) | (188.46%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(108.66%) | (103.21%) | (643.26%) | (568.83%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.29) | (1.52) | (1.77) | (1.60) | |
Free Cash Flow |
(21.20) | (18.28) | (18.02) | (16.58) | |
Capital Expenditures |
(0.07) | (0.08) | (0.06) | (0.07) | |
| Other line items | |||||
Cash ROIC |
(47.13%) | (40.30%) | (301.01%) | (126.02%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | (0.01) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.86 | 0.94 | 0.88 | |
Depreciation/Fixed assets |
0.57 | 0.42 | 0.28 | 0.19 | |
Capex/Depreciation |
(0.24) | (0.43) | (0.49) | (0.59) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.29) | (1.51) | (1.76) | (1.60) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates